Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

This study has been completed.
Information provided by (Responsible Party):
MolMed S.p.A. Identifier:
First received: May 5, 2008
Last updated: May 29, 2014
Last verified: May 2014